Skip to content

Clinical trials

Phase 1/2 Pancreatic Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1/2 Country / region: Japan Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20071
20082
20161
20201
20212
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Unknown status3
Completed2
Recruiting1
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fukushima Medical University2
Tokyo University2
AstraZeneca1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1
Hokkaido Gastrointestinal Cancer Study Group1
Kyushu University1
Nagoya University1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms11
Carcinoma, Non-Small-Cell Lung3
Endometrial Neoplasms3
Stomach Neoplasms3
Biliary Tract Neoplasms2
Colorectal Neoplasms2
Neoplasms2
Ovarian Neoplasms2
Breast Neoplasms1
Melanoma1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.